natgillin/translations-raw huggingface dataset:
Each Party shall provide for appropriate civil judicial procedures and remedies for any trade secret holder to prevent, and obtain redress for, the acquisition, use or disclosure of a trade secret whenever carried out in a manner contrary to honest commercial practices.
Vsaka pogodbenica vsem imetnikom poslovnih skrivnosti zagotovi ustrezne civilne sodne postopke in pravna sredstva, s katerimi se preprečijo pridobitev, uporaba ali razkritje poslovne skrivnosti ter pridobijo pravna sredstva v zvezi s tem, če se ti izvedejo na način, ki je v nasprotju s pošteno poslovno prakso.
For purposes of this Subsection:
V tem pododdelku:
‘trade secret’ means information that:
„poslovna skrivnost“ pomeni informacijo, da:
is secret in the sense that it is not, as a body or in the precise configuration and assembly of its components, generally known among or readily accessible to persons within the circles that normally deal with the kind of information in question;
je skrivnost v smislu, da njena celota ali natančna konfiguracija in sestava njenih komponent ni splošno znana ali lahko dosegljiva osebam v krogih, ki se običajno ukvarjajo s to vrsto informacij;
has commercial value because it is secret; and
ima tržno vrednost, ker je tajna; in
has been subject to reasonable steps under the circumstances, by the person lawfully in control of the information, to keep it secret; and
je oseba, ki ima zakoniti nadzor nad to informacijo, v danih okoliščinah razumno ukrepala, da jo ohrani kot skrivnost; ter
‘trade secret holder’ means any natural or legal person lawfully controlling a trade secret.
„imetnik poslovne skrivnosti“ pomeni vsako fizično ali pravno osebo, ki ima zakoniti nadzor nad poslovno skrivnostjo.
For the purpose of this Subsection, at least the following forms of conduct shall be considered contrary to honest commercial practices:
Za namene tega pododdelka se vsaj za naslednje oblike ravnanja šteje, da so v nasprotju s pošteno poslovno prakso:
the acquisition of a trade secret without the consent of the trade secret holder, whenever carried out through unauthorised access to, appropriation of, or copying of any documents, objects, materials, substances or electronic files lawfully under the control of the trade secret holder which contain the trade secret or from which the trade secret can be deduced;
pridobitev poslovne skrivnosti brez privolitve imetnika poslovne skrivnosti, kadar koli do tega pride z nepooblaščenim dostopom do katerih koli dokumentov, predmetov, gradiva, vsebin ali elektronskih datotek, ki so pod zakonitim nadzorom imetnika poslovne skrivnosti in vsebujejo poslovno skrivnost ali je iz njih mogoče ugotoviti poslovno skrivnost, oziroma njihovo prilastitvijo ali kopiranjem;
the use or disclosure of a trade secret whenever carried out, without the consent of the trade secret holder, by a person who is found to:
uporaba ali razkritje poslovne skrivnosti, kadar koli to brez privolitve imetnika poslovne skrivnosti stori oseba, za katero je ugotovljeno, da:
have acquired the trade secret in a manner referred to in point (a);
je pridobila poslovno skrivnost na način iz točke (a);
be in breach of a confidentiality agreement or any other duty not to disclose the trade secret; or
krši dogovor o zaupnosti ali katero koli drugo dolžnost molčečnosti v zvezi s poslovno skrivnostjo; ali
be in breach of a contractual or any other duty to limit the use of the trade secret; and
krši pogodbeno ali katero koli drugo dolžnost omejitve uporabe poslovne skrivnosti; ter
the acquisition, use or disclosure of a trade secret whenever carried out by a person who, at the time of the acquisition, use or disclosure, knew or ought, under the circumstances, to have known that the trade secret had been obtained directly or indirectly from another person who was using or disclosing the trade secret unlawfully within the meaning of point (b), including where a person has induced another person to carry out the actions referred to in that point.
pridobitev, uporaba ali razkritje poslovne skrivnosti, kadar koli je oseba, ki je to storila, v času pridobitve, uporabe ali razkritja vedela ali bi morala v danih okoliščinah vedeti, da je poslovno skrivnost neposredno ali posredno pridobila od druge osebe, ki je poslovno skrivnost uporabila ali razkrila nezakonito v smislu točke (b), tudi kadar ena oseba pregovori drugo osebo, da izvede dejanja iz te točke.
Nothing in this Subsection shall be understood as requiring a Party to consider any of the following forms of conduct as contrary to honest commercial practices:
Nobena določba tega pododdelka ne zahteva od pogodbenice, da za katero koli od naslednjih oblik ravnanja šteje, da je v nasprotju s pošteno poslovno prakso:
independent discovery or creation by a person of the relevant information;
oseba neodvisno odkrije ali ustvari ustrezne informacije;
reverse engineering of a product by a person who is lawfully in possession of it and who is free from any legally valid duty to limit the acquisition of the relevant information;
obratni inženiring proizvoda s strani osebe, ki jo ima zakonito v lasti in ki je ne zavezuje nobena pravno veljavna dolžnost, da omeji pridobitev ustreznih informacij;
acquisition, use or disclosure of information required or allowed by the relevant domestic law; and
pridobitev, uporaba ali razkritje informacij, ki se zahtevajo ali jih dovoljuje ustrezno domače pravo; ter
use by employees of their experience and skills honestly acquired in the normal course of their employment.
uporaba izkušenj ter znanja in spretnosti zaposlenih, ki so jih pošteno pridobili med rednim opravljanjem dela.
Nothing in this Subsection shall be understood as restricting freedom of expression and information, including media freedom as protected in the jurisdiction of each of the Parties.
Nobena določba tega pododdelka ne omejuje svobode izražanja in obveščanja, vključno s svobodo medijev, kot je zaščitena v jurisdikciji vsake pogodbenice.
Article 250
Člen 250
Civil judicial procedures and remedies for trade secrets
Civilni sodni postopki in pravna sredstva za poslovne skrivnosti
Each Party shall ensure that any person participating in the civil judicial proceedings referred to in Article 249, or who has access to documents which form part of those legal proceedings, is not permitted to use or disclose any trade secret or alleged trade secret which the competent judicial authorities have, in response to a duly reasoned application by an interested party, identified as confidential and of which they have become aware as a result of such participation or access.
Vsaka pogodbenica zagotovi, da nobeni osebi, ki sodeluje v civilnih sodnih postopkih iz člena 249 ali ima dostop do dokumentov, ki so del tega sodnega postopka, ni dovoljeno uporabiti ali razkriti nobene poslovne skrivnosti ali domnevne poslovne skrivnosti, ki so jo pristojni sodni organi v odziv na ustrezno utemeljeno vlogo zainteresirane strani opredelili za zaupno in bili z njo seznanjeni na podlagi te udeležbe ali dostopa.
In the civil judicial proceedings referred to in Article 249, each Party shall provide that its judicial authorities have the authority at least to:
V civilnih sodnih postopkih iz člena 249 vsaka pogodbenica zagotovi, da so njeni sodni organi pooblaščeni vsaj za:
order provisional measures to prevent the acquisition, use or disclosure of the trade secret in a manner contrary to honest commercial practices;
odredbo začasnih ukrepov, da bi preprečili pridobitev, uporabo ali razkritje poslovne skrivnosti na način, ki je v nasprotju s pošteno poslovno prakso;
order injunctive relief to prevent the acquisition, use or disclosure of the trade secret in a manner contrary to honest commercial practices;
odredbo sodne prepovedi, da bi preprečili pridobitev, uporabo ali razkritje poslovne skrivnosti na način, ki je v nasprotju s pošteno poslovno prakso;
order the person that knew or ought to have known that he, she or it was acquiring, using or disclosing a trade secret in a manner contrary to honest commercial practices to pay the trade secret holder damages appropriate to the actual prejudice suffered as a result of such acquisition, use or disclosure of the trade secret;
odredbo osebi, ki je vedela ali bi morala vedeti, da je pridobila, uporabila ali razkrila poslovno skrivnost na način, ki je v nasprotju s pošteno poslovno prakso, da imetniku poslovne skrivnosti plača odškodnino, ki ustreza dejanski škodi, ki jo je utrpel zaradi te pridobitve, uporabe ali razkritja poslovne skrivnosti;
take specific measures to preserve the confidentiality of any trade secret or alleged trade secret produced in civil proceedings relating to the alleged acquisition, use and disclosure of a trade secret in a manner contrary to honest commercial practices; such specific measures may include, in accordance with the domestic law of the relevant Party, the possibility of:
sprejetje posebnih ukrepov za ohranitev zaupnosti katere koli poslovne skrivnosti ali domnevne poslovne skrivnosti, nastale v civilnem postopku, ki se nanaša na domnevno pridobitev, uporabo in razkritje poslovne skrivnosti na način, ki je v nasprotju s pošteno poslovno prakso; ti posebni ukrepi lahko v skladu z domačim pravom zadevne pogodbenice vključujejo možnost:
restricting access to certain documents in whole or in part;
omejevanja dostopa do nekaterih dokumentov v celoti ali delno;
restricting access to hearings and their corresponding records or transcript; and
omejevanja dostopa do obravnav in ustreznih zapisnikov ali dobesednih zapisov teh obravnav; ter
making available a non-confidential version of a judicial decision in which the passages containing trade secrets have been removed or redacted; and
dajanja na voljo nezaupne različice sodne odločbe, v kateri so odlomki, ki vsebujejo poslovne skrivnosti, odstranjeni ali redigirani; ter
impose sanctions on parties, or other persons subject to the court's jurisdiction, for the violation of remedies or measures adopted by the court pursuant to paragraph 1 or point (d) of this paragraph concerning the protection of a trade secret or alleged trade secret produced in those proceedings.
naložitve sankcij pogodbenicama ali drugim osebam, za katere je pristojno to sodišče, zaradi kršitve pravnih sredstev ali ukrepov, ki jih je sodišče sprejelo v skladu z odstavkom 1 ali točko (d) tega odstavka v zvezi z varovanjem poslovne skrivnosti ali domnevne poslovne skrivnosti, nastale v teh postopkih.
The Parties shall not be required to provide for the judicial procedures and remedies referred to in Article 249 when the conduct contrary to honest commercial practices is carried out, in accordance with their relevant domestic law, to reveal misconduct, wrongdoing or illegal activity or for the purpose of protecting a legitimate interest recognised by law.
Od pogodbenic se ne zahteva, da zagotovijo sodne postopke in pravna sredstva iz člena 249 v primeru ravnanja v nasprotju s pošteno poslovno prakso, v skladu z zadevnim domačim pravom, da se razkrijejo kršitve, nepravilno ravnanje ali nezakonite dejavnosti z namenom zaščite legitimnih interesov, ki jih priznava pravo.
Article 251
Člen 251
Protection of data submitted to obtain an authorisation to put a medicinal product on the market
Varstvo podatkov, predloženih za namene pridobitve dovoljenja za dajanje zdravila na trg
Each Party shall protect commercially confidential information submitted to obtain an authorisation to put a medicinal product on the market (‘marketing authorisation’) against disclosure to third parties, unless overriding health interests provide otherwise.
Vsaka pogodbenica zaščiti zaupne poslovne informacije, predložene za pridobitev dovoljenja za dajanje zdravila na trg (v nadaljnjem besedilu: dovoljenje za promet), pred razkritjem tretjim osebam, razen če višji interesi, povezani z zdravjem, določajo drugače.
Any confidential business information shall also benefit from protection against unfair commercial practices.
Vse zaupne poslovne informacije so prav tako upravičene do zaščite pred nepošteno poslovno prakso.
Each Party shall ensure that, for a period of eight years from the first marketing authorisation in the Party concerned, the public body responsible for the granting of a marketing authorisation shall not take into account confidential business information or the results of pre-clinical tests or clinical trials provided in the first marketing authorisation application and subsequently submitted by a person or entity, whether public or private, in support of another application for authorisation to place a medicinal product on the market without the explicit consent of the person or entity who submitted such data, unless international agreements recognised by both Parties provide otherwise.
Vsaka pogodbenica zagotovi, da v obdobju osmih let od prvega dovoljenja za promet v zadevni pogodbenici, javni organ, pristojen za izdajo dovoljenja za promet, ne upošteva zaupnih poslovnih informacij ali rezultatov predkliničnega ali kliničnega preskušanja, ki so bili zagotovljeni v prvi vlogi za dovoljenje za promet in jih je nato predložila oseba ali subjekt, javni ali zasebni, v podporo drugi vlogi za dovoljenje za dajanje zdravila na trg brez izrecne privolitve osebe ali subjekta, ki je predložil te podatke, razen če mednarodni sporazumi, ki jih priznavata obe pogodbenici, določajo drugače.
During a ten-year period, starting from the date of granting of the first marketing authorisation in the Party concerned, a marketing authorisation granted for any subsequent application based on the results of pre-clinical tests or of clinical trials provided in the first marketing authorisation shall not permit placing a medicinal product on the market, unless the subsequent applicant submits his own results of pre-clinical tests or of clinical trials (or results of pre-clinical tests or of clinical trials used with the consent of the party which had provided that information) fulfilling the same requirements as the first applicant.
V desetletnem obdobju od datuma izdaje prvega dovoljenja za promet v zadevni pogodbenici, dovoljenje za promet, izdano za vsako naslednjo vlogo na podlagi rezultatov predkliničnega ali kliničnega preskušanja, zagotovljenih v prvem dovoljenju za promet, ne dovoljuje dajanja zdravil na trg, razen če poznejši vložnik predloži svoje rezultate predkliničnega ali kliničnega preskušanja (ali rezultate predkliničnega ali kliničnega preskušanja, uporabljene s privolitvijo pogodbenice, ki je zagotovila te informacije), ki izpolnjujejo iste zahteve kot prvi vložnik.
Products not complying with the requirements set out in this paragraph shall not be allowed on the market.
Proizvodi, ki ne izpolnjujejo zahtev iz tega odstavka, se ne smejo dati na trg.
In addition, the ten-year period referred to in paragraph 3 shall be extended to a maximum of 11 years if, during the first eight years after obtaining the authorisation, the authorisation holder obtains authorisation for one or more new therapeutic indications which are considered to bring a significant clinical benefit in comparison with existing therapies.
Poleg tega se desetletno obdobje iz odstavka 3 podaljša za največ 11 let, če v prvih osmih letih po pridobitvi dovoljenja imetnik dovoljenja pridobi dovoljenje za eno ali več novih terapevtskih indikacij, ki naj bi prinesle pomembno klinično korist v primerjavi z obstoječimi terapijami.
Article 252
Člen 252
Data protection on plant protection products
Varstvo podatkov o fitofarmacevtskih sredstvih
Each Party shall recognise a temporary right of the owner of a test or study report submitted for the first time to obtain a marketing authorisation for a plant protection product.
Pogodbenici lastniku poročila o preskusu ali študiji, ki je bilo prvič predloženo za pridobitev dovoljenja za promet s fitofarmacevtskim sredstvom, priznata začasno pravico.
During such period, the test or study report shall not be used for the benefit of any other person aiming to obtain a marketing authorisation for a plant protection product, except when the explicit consent of the first owner is given.
V takem obdobju se poročilo o preskusu ali študiji ne uporabi v korist nobene druge osebe, ki želi pridobiti dovoljenje za promet s fitofarmacevtskim sredstvom, razen če da prvi lastnik izrecno privoljenje za to.
In this Subsection that temporary right is referred to as ‘data protection’.
V tem pododdelku se ta začasna pravica imenuje „varstvo podatkov“.
The test or study report referred to in paragraph 1 shall fulfil the following conditions:
Poročilo o preskusu ali študiji iz odstavka 1 mora izpolnjevati naslednje pogoje:
be necessary for the authorisation or an amendment of an authorisation in order to allow the use on other crops; and
namenjeno je odobritvi ali spremembi dovoljenja, da se dovoli uporaba na drugem pridelku; ter
be certified as compliant with the principles of good laboratory practice or of good experimental practice.
potrjeno je kot skladno z načeli dobre laboratorijske prakse ali dobre preskusne prakse.
The period of data protection shall be at least ten years from the first authorisation granted by the competent authority in the Party concerned.
Obdobje varstva podatkov traja vsaj deset let od prvega dovoljenja, ki ga izda pristojni organ v zadevni pogodbenici.
For low-risk plant protection products, the period may be extended to 13 years.
Za fitofarmacevtska sredstva z majhnim tveganjem se to obdobje lahko podaljša na 13 let.
The periods referred to in paragraph 3 shall be extended by three months for each extension of authorisation for minor uses if the applications for such authorisations are made by the authorisation holder at least five years after first authorisation granted by the competent authority.
Obdobja iz odstavka 3 se podaljšajo za tri mesece ob vsakem podaljšanju dovoljenja za uporabo v manjši meri, če imetnik dovoljenja predloži vloge za pridobitev takih dovoljenj vsaj pet let po datumu prvega dovoljenja, ki ga izda pristojni organ.
The total period of data protection may in no circumstances exceed 13 years.
Celotno obdobje varstva podatkov ne sme v nobenih okoliščinah presegati 13 let.
For low-risk plant protection products, the total period of data protection may in no circumstances exceed 15 years.
Za fitofarmacevtska sredstva z majhnim tveganjem ne sme celotno obdobje varstva podatkov v nobenih okoliščinah presegati 15 let.
The term ‘minor use’ means use in a Party's territory of a plant protection product on plants or plant products which are not widely grown in that Party or widely grown to meet an exceptional need for plant protection.
Izraz „uporaba v manjši meri“ pomeni, da se na ozemlju pogodbenice fitofarmacevtsko sredstvo uporablja na rastlinah ali rastlinskih proizvodih, ki v tej pogodbenici niso splošno razširjeni ali niso tako splošno razširjeni, da bi obstajala izjemna potreba po varstvu rastlin.
A test or study shall also be protected if it was necessary for the renewal or review of an authorisation.
Preskus ali študija se varujeta tudi, če sta bila potrebna za podaljšanje ali pregled dovoljenja.
In such cases, the period of data protection shall be 30 months.
V takih primerih je obdobje varstva podatkov 30 mesecev.
Measures obliging the applicant and holders of previous authorisations, established in the Parties' respective territories, to share proprietary information so as to avoid duplicative testing on vertebrate animals, shall be laid down by each Party.
Vsaka pogodbenica določi ukrepe, ki zavezujejo vložnika in imetnike predhodnih dovoljenj s sedežem na ozemljih pogodbenic k izmenjavi zaščitenih informacij, da bi se izognili podvajanju preskusov na vretenčarjih.
Plant varieties
Sorte rastlin
Article 253
Člen 253
Each Party shall protect plant variety rights, in accordance with the International Convention for the Protection of New Varieties of Plants (‘UPOV’), including the exceptions to the breeder's right as referred to in Article 15 of that Convention, and cooperate to promote and enforce those rights.
Vsaka pogodbenica varuje žlahtniteljske pravice v skladu z Mednarodno konvencijo o varstvu novih sort rastlin (v nadaljnjem besedilu: Konvencija UPOV), vključno z izjemami k pravici žlahtnitelja iz člena 15 navedene konvencije, ter sodeluje pri spodbujanju in uveljavljanju teh pravic.
For the Republic of Armenia, this Article shall apply no later than three years after the entry into force of this Agreement.
Za Republiko Armenijo se ta člen uporablja najpozneje tri leta po začetku veljavnosti tega sporazuma.
Enforcement of intellectual property rights
Uveljavljanje pravic intelektualne lastnine
Article 254
Člen 254
The Parties reaffirm their commitments under the TRIPS Agreement, in particular Part III thereof.
Pogodbenici ponovno potrjujeta svoje zaveze v okviru Sporazuma TRIPS, zlasti dela III Sporazuma TRIPS.
Each Party shall provide for the complementary measures, procedures and remedies in this Section which are necessary to ensure the enforcement of intellectual property rights.
Vsaka pogodbenica v tem oddelku zagotovi dopolnilne ukrepe, postopke in pravna sredstva, potrebne za zagotavljanje uveljavljanja pravic intelektualne lastnine.
Those measures, procedures and remedies shall be fair and equitable, and shall not be unnecessarily complicated or costly, or entail unreasonable time-limits or unwarranted delays.
Ti ukrepi, postopki in korektivni ukrepi morajo biti pošteni in pravični ter ne smejo biti po nepotrebnem zapleteni ali dragi ali določati nerazumnih rokov ali povzročati neupravičenih zamud.
The measures, procedures and remedies referred to in paragraph 1 shall be effective, proportionate and dissuasive and shall be applied in such a manner as to avoid the creation of barriers to legitimate trade and to provide for safeguards against their abuse.
Ukrepi, postopki in korektivni ukrepi iz odstavka 1 morajo biti učinkoviti, sorazmerni in odvračilni, uporabljati pa se morajo na način, ki omogoča preprečevanje ovir zakonitemu trgovanju in zagotavlja zaščito pred njihovo zlorabo.
For the purposes of Subsection II of this Section, the notion of ‘intellectual property rights’ includes at least the following:
V pododdelku II tega oddelka pojem „pravice intelektualne lastnine“ vključuje vsaj naslednje:
copyright;
avtorske pravice;
rights related to copyright;
pravice, povezane z avtorskimi pravicami;
sui generis right of a database maker;
sui generis pravico izdelovalca zbirke podatkov;
rights of the creator of the topographies of a semiconductor product;
pravice ustvarjalca topografij polprevodniškega proizvoda;
trademark rights;
pravice iz blagovne znamke;
design rights;
pravice iz modela;
patent rights, including rights derived from supplementary protection certificates;
pravice iz patenta (vključno s tistimi, ki izhajajo iz dodatnih varstvenih certifikatov);
geographical indications;
geografske označbe;
utility model rights;
pravice iz uporabnega modela;
plant variety rights; and
žlahtniteljske pravice; ter
trade names in so far as these are protected as exclusive rights in the domestic law concerned.
trgovska imena, če jih zadevno domače pravo ščiti kot izključne pravice.
Trade secrets are excluded from the scope of this Section.
Poslovne skrivnosti so izključene iz področja uporabe tega oddelka.
Enforcement of trade secrets is addressed in Article 250.
Uveljavljanje poslovnih skrivnosti je obravnavano v členu 250.
Article 255
Člen 255
Entitled applicants
Upravičeni vložniki
Each Party shall recognise as persons entitled to seek application of the measures, procedures and remedies referred to in this Section and in Part III of the TRIPS Agreement:
Vsaka pogodbenica za osebe, ki imajo pravico zahtevati izvedbo ukrepov, postopkov in korektivnih ukrepov iz tega oddelka in iz dela III Sporazuma TRIPS, priznava:
the holders of intellectual property rights, in accordance with the applicable law;
imetnike pravic intelektualne lastnine v skladu s pravom, ki se uporablja;
all other persons authorised to use those rights, in particular licensees, in so far as permitted by and in accordance with the applicable law;
vse druge osebe, pooblaščene za uporabo teh pravic, zlasti imetnike licence, kolikor je to dovoljeno in v skladu s pravom, ki se uporablja;